Dr. Liow is an NIH trained research neurologist who established Hawaii’s first fully integrated multidisciplinary neuroscience team of over 10 physicians and researchers serving over 25,000 clinical and over 300 research visits in 2016 from all Islands. His team is currently investigating ground breaking phase I-IV clinical trials like the first disease modifying drug BACE-Inhibitor for Alzheimer’s, innovative method to abort acute Seizures in phase I pharmacokinetic studies, novel method to deliver inhalational medications in Parkinson’s patients and other investigations in Stroke, Pediatric Epilepsy, Multiple Sclerosis and other neurological conditions. Dr. Liow is the Director of Neuroscience and also Chief of Medicine at Adventist Health Castle and Clinical Professor of Neurology at the University of Hawaii John Burns School of Medicine. He directs the largest neuroscience teaching program in Hawaii in 2016 with over 50 residents, medical students, and post-doctorate, graduate, undergraduate and research students.
Born in Penang Island, Malaysia and grew up in Singapore, Liow was awarded President Ronald Reagan’s Scholarship to study medicine at St George’s University in Grenada, West Indies before completing his neurology residency at the University of Utah School of Medicine and then fellowship training in Neurophysiology at NINDS, NIH (National Institutes of Health) where he started his clinical research career at NIH Clinical Center or the world’s largest research hospital located in Bethesda, Maryland. He began his research looking at the effect of TMS (Transcranial Magnetic Stimulation) and how it affects cortical excitability. After NIH, he went on to establish and directed one of the busiest Neuroscience Center in Midwest US where he cared for patients from Kansas, Oklahoma, Colorado, Missouri and Nebraska and rose through the academic rank to Professor of Neurology at the University of Kansas Medical School. Liow is a licensed board certified neurologist who spends majority of his time in research and successfully served as principal investigator (PI) or site PI for over 70 phase I-IV clinical trials in neuroscience sponsored by the NIH, CDC and the industries. He is a nationally recognized and sough after key opinion leader in neuroscience having published over 40 peer reviewed publications and asked to serve on national advisory panel for the CDC, American Academy of Neurology and drafted position statements for these national organizations. He is serving on editorial board/reviewer for various neurology and neuroscience journals and is the current editor for the Neurology Section of the ACP (American College of Physician) Smart Medicine.